Not recommended
Human studies show no meaningful benefit, potential harm, or the risks outweigh any possible upside. Better alternatives exist.
Also known as: trans-pterostilbene, blueberry stilbene
Latest evidence update: 2005-05-04
Strongest in Study quality (71). Held back by Replication (18).
Solid mix of RCTs with some methodological gaps.
Few independent replications; results not yet robust.
Small combined sample; treat as preliminary.
Mixed direction across studies.
Mostly pre-2020 research; updates may be needed.
No quantified outcomes yet. Once we have studies with measurable endpoints, you will see per-outcome magnitude here.
Recommended: 50–250 mg daily (animal-extrapolated; human optimal dose unknown)
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.